Business Wire

MedTest Dx Manufactures the Only FDA Approved Quantitative Test for G6PD, Critical when Considering COVID-19 Treatment with Chloroquine and Hydroxychloroquine

-Accurate, Plug and Play Test Measures G6PD Activity in Whole Blood, Detecting Both Presence and Severity of G6PD Deficiency, Providing Key Insight to Inform Drug Therapy Options CANTON, ...
WLNS.com

Baebies Receives FDA 510(k) Clearance for G6PD Test on FINDER Platform

DURHAM, N.C., Nov. 9, 2022 /PRNewswire/ -- Baebies has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its rapid, point-of-care test for glucose-6-phosphate dehydrogenase (G6PD) ...
Nature

Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States?

Glucose-6-phosphate dehydrogenase (G6PD) deficiency, a common X-linked enzymopathy can lead to severe hyperbilirubinemia, acute bilirubin encephalopathy and kernicterus in the United States. Neonatal ...
MedPage Today

Does G6PD Deficiency Relate to COVID-19 Infection?

In an April 8 MedPage Today article, Mark Zucker, MD, asked the question as to why there is differential susceptibility to COVID-19 infection. In other words, why do some people become severely ill ...
Pharmabiz

US FDA grants 510(k) clearance for Baebies G6PD test on FINDER platform

Baebies has received US Food and Drug Administration (FDA) 510(k) clearance for its rapid, point-of-care test for glucose-6-phosphate dehydrogenase (G6PD) deficiency. The test is run on the FINDER ...